KLEO PHARMACEUTICALS Trademark

Trademark Overview


On Thursday, December 16, 2021, a trademark application was filed for KLEO PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the KLEO PHARMACEUTICALS trademark a serial number of 97175804. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The KLEO PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders; none of the foregoing to include nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant

Discovery, research and development, testing, collaboration in the nature of providing scientific research and product development in the field of pharmaceuticals, excluding all services in the field of medical tubing for infusion therapy, and also excluding all services relating to apparatus and instruments for infusing medication in the nature of infusion sets consisting of cannulae inserters, needle inserters, needle retractors, site or hub, adhesive dressing or tape, tubing, and connectors for use with insulin pumps, needles, cannulae, connectors and couplings for medical apparatus and instruments for infusing medications; none of the foregoing to include services related to nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant
kleo pharmaceuticals

General Information


Serial Number97175804
Word MarkKLEO PHARMACEUTICALS
Filing DateThursday, December 16, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical products for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders; none of the foregoing to include nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesDiscovery, research and development, testing, collaboration in the nature of providing scientific research and product development in the field of pharmaceuticals, excluding all services in the field of medical tubing for infusion therapy, and also excluding all services relating to apparatus and instruments for infusing medication in the nature of infusion sets consisting of cannulae inserters, needle inserters, needle retractors, site or hub, adhesive dressing or tape, tubing, and connectors for use with insulin pumps, needles, cannulae, connectors and couplings for medical apparatus and instruments for infusing medications; none of the foregoing to include services related to nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Trademark Events


Event DateEvent Description
Monday, December 20, 2021NEW APPLICATION ENTERED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023NON-FINAL ACTION WRITTEN
Thursday, April 13, 2023NON-FINAL ACTION E-MAILED
Thursday, April 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, June 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 27, 2023FINAL REFUSAL WRITTEN
Monday, November 27, 2023FINAL REFUSAL E-MAILED
Monday, November 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 14, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, December 14, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, December 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 14, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, December 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 23, 2024SOU EXTENSION 1 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED